Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-09 | New | $650,000 | $650,000 | Debt Only | 06b | SEC link |
2025-03-27 | New | $748,052 | $748,052 | Debt Only | 06b | SEC link |
2023-08-04 | New | $236,000 | $236,000 | Debt Only | 06b | SEC link |
2019-10-02 | New | $752,703 | $752,703 | Debt Only | 06b | SEC link |
2017-07-19 | Amended | $1,817,575 | $1,251,672 | Equity Only | 06b | SEC link |
2017-06-26 | New | $565,903 | $565,903 | Equity Only | 06b | SEC link |
2016-06-15 | New | $400,000 | $400,000 | Equity and Debt | 06b | SEC link |
Name | Role |
---|---|
Solomon Aronson | Director |
Benton Barney | Director |
Brad Busse | Director |
John Cochran | Director |
Muscle Sound Investment Co., Llc | Director |
Andy Jackson | Executive |
William King | Director |
Stephen Kurtz | Director, Executive |
Ryan Minatta | Executive |
N/A Muscle Sound Investment Co., Llc | Director |
William Powell | Director |
Michael Rainen | Director |
David Ramich | Executive |